Hub gene identification and molecular subtype construction for Helicobacter pylori in gastric cancer via machine learning methods and NMF algorithm.
暂无分享,去创建一个
Zhengrong Li | Yi Cao | Zongfeng Feng | Y. Tu | Xufeng Shu | Qing-Xuan Zeng | Ahao Wu | Lianghua Luo | Tengcheng Hu | Li Liu | Zhonghao Wang
[1] P. Lin,et al. EFNA3 is a prognostic biomarker for the overall survival of hepatocellular carcinoma patients. , 2022, Journal of Hepatology.
[2] I. Ng,et al. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. , 2022, Journal of hepatology.
[3] Yang Zhang,et al. RNF114 Silencing Inhibits the Proliferation and Metastasis of Gastric Cancer , 2022, Journal of Cancer.
[4] Fangzhou Song,et al. LncRNA SNHG3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-139-5p/MYB axis , 2021, Aging.
[5] F. Cedrón,et al. A review on machine learning approaches and trends in drug discovery , 2021, Computational and structural biotechnology journal.
[6] Weimin Ma,et al. Role of NRP1 in Bladder Cancer Pathogenesis and Progression , 2021, Frontiers in Oncology.
[7] S. Lera,et al. Uncovering feature interdependencies in high-noise environments with stepwise lookahead decision forests , 2021, Scientific Reports.
[8] K. Matsuo,et al. Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review. , 2021, Japanese journal of clinical oncology.
[9] Qianlan Yao,et al. Impaired AGO2/miR-185-3p/NRP1 axis promotes colorectal cancer metastasis , 2021, Cell Death & Disease.
[10] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[11] Hao Liu,et al. FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis , 2020, Oncogene.
[12] Frederick M. Howard,et al. Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer , 2020, JAMA network open.
[13] Xuancheng Lu,et al. Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells , 2020, Frontiers in Oncology.
[14] Nayoung Kim,et al. Promising aberrant DNA methylation marker to predict gastric cancer development in individuals with family history and long-term effects of H. pylori eradication on DNA methylation , 2020, Gastric Cancer.
[15] J. Wei,et al. Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10. , 2020, European review for medical and pharmacological sciences.
[16] R. Safaralizadeh,et al. Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects , 2020, Cancer medicine.
[17] Vanesa Segovia Bucheli,et al. A comparative study of machine learning and deep learning algorithms to classify cancer types based on microarray gene expression data , 2020, PeerJ Comput. Sci..
[18] P. Portincasa,et al. Mechanisms of the Epithelial–Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer , 2020, Cells.
[19] D. Metz,et al. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study. , 2020, Gastroenterology.
[20] C. Adinortey,et al. Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation , 2019, BioMed research international.
[21] Jian Li,et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. , 2019, Cancer letters.
[22] Linyan Zhou,et al. FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway. , 2019, Biochemical and biophysical research communications.
[23] M. Poljak,et al. Helicobacter pylori virulence genes , 2019, World journal of gastroenterology.
[24] A. Vilanova,et al. PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors , 2019, Journal of Immunotherapy for Cancer.
[25] V. Santosh,et al. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma , 2019, Journal of Clinical Pathology.
[26] Xiaowu Xu,et al. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. , 2019, Cancer letters.
[27] Chen Ding,et al. Quantum-Inspired Support Vector Machine , 2019, IEEE Transactions on Neural Networks and Learning Systems.
[28] A. Rotte,et al. Combination of CTLA-4 and PD-1 blockers for treatment of cancer , 2019, Journal of Experimental & Clinical Cancer Research.
[29] Kun Wu,et al. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling , 2019, Bioscience reports.
[30] Rochelle L. Tiedemann,et al. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. , 2019, Cancer cell.
[31] E. Jaffee,et al. PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. , 2019, JCI insight.
[32] A. Jemal,et al. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997–2014 , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] P. Malfertheiner,et al. Helicobacter pylori Infection: New Facts in Clinical Management , 2018, Current Treatment Options in Gastroenterology.
[34] Qiong Zhang,et al. GSCALite: a web server for gene set cancer analysis , 2018, Bioinform..
[35] Chang-qing Yang,et al. UHRF1 mediates cell migration and invasion of gastric cancer , 2018, Bioscience reports.
[36] A. Reyniès,et al. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies , 2018, Cancer Immunology, Immunotherapy.
[37] Feng Liu,et al. Deep Learning and Its Applications in Biomedicine , 2018, Genom. Proteom. Bioinform..
[38] C. Lindskog,et al. The human protein atlas: A spatial map of the human proteome , 2018, Protein science : a publication of the Protein Society.
[39] M. Ringnér,et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.
[40] J. Meléndez-Zajgla,et al. NRP1-positive lung cancer cells possess tumor-initiating properties , 2017, Oncology reports.
[41] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[42] Jing Xu,et al. Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma , 2017, PloS one.
[43] Lihua Li,et al. Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10 , 2017, Oncology reports.
[44] Huiqin Chen,et al. Support Vector Machine Classification of Drunk Driving Behaviour , 2017, International journal of environmental research and public health.
[45] D. Graham,et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. , 2016, Gastroenterology.
[46] Nicolai J. Birkbak,et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.
[47] Fan Yang,et al. An experimental study of the intrinsic stability of random forest variable importance measures , 2016, BMC Bioinformatics.
[48] Rahul C. Deo,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[49] F. Mégraud,et al. Epidemiology and Diagnosis of Helicobacter pylori infection , 2015, Helicobacter.
[50] Martin L. Miller,et al. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer , 2015, Science.
[51] Helena Carreira,et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.
[52] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[53] I. Pinchuk,et al. Immune evasion strategies used by Helicobacter pylori. , 2014, World journal of gastroenterology.
[54] W. Park,et al. The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer. , 2014, Gene.
[55] Z. Tulassay,et al. Helicobacter pylori infection: new pathogenetic and clinical aspects. , 2014, World journal of gastroenterology.
[56] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[57] Raquel Seruca,et al. Helicobacter pylori infection generates genetic instability in gastric cells. , 2010, Biochimica et biophysica acta.
[58] M. Piazuelo,et al. Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.
[59] Christian Fischer,et al. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.
[60] Mario Plebani,et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.
[61] P. Malfertheiner,et al. Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique , 2005, The American Journal of Gastroenterology.
[62] J. Goedert,et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.
[63] E. Lesaffre,et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. , 1996, International journal of epidemiology.
[64] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.
[65] Ash A. Alizadeh,et al. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.